Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Active Biotech
Biotech
Israeli biotech NeoTX lands $45M series C for combo cancer test
NeoTX Therapeutics has nabbed a healthy $45 million third funding round as it looks to continue work on its early-stage cancer combo test.
Ben Adams
Feb 19, 2020 7:15am
Teva finally dumps laquinimod, ending failure-riddled saga
Sep 5, 2018 10:41am
Active Bio, Teva’s laquinimod fails once more, in Huntington’s
Jul 31, 2018 11:15am
Active Bio and Teva’s laquinimod strikes out in MS again
Dec 1, 2017 10:53am
Teva’s Copaxone heir fails again in multiple sclerosis phase 3
May 8, 2017 4:27am
